Natixis Acquires 38,829 Shares of Colgate-Palmolive (NYSE:CL)

Natixis raised its stake in shares of Colgate-Palmolive (NYSE:CL) by 25.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 190,167 shares of the company’s stock after acquiring an additional 38,829 shares during the period. Natixis’ holdings in Colgate-Palmolive were worth $17,288,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CL. Norinchukin Bank The grew its position in Colgate-Palmolive by 10.1% in the 4th quarter. Norinchukin Bank The now owns 37,426 shares of the company’s stock worth $3,402,000 after purchasing an additional 3,433 shares during the period. BI Asset Management Fondsmaeglerselskab A S boosted its stake in shares of Colgate-Palmolive by 70.1% in the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 389,020 shares of the company’s stock worth $35,366,000 after buying an additional 160,340 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Colgate-Palmolive by 5.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,978,685 shares of the company’s stock worth $361,700,000 after buying an additional 220,326 shares during the last quarter. Forum Financial Management LP increased its position in Colgate-Palmolive by 24.6% during the fourth quarter. Forum Financial Management LP now owns 5,513 shares of the company’s stock valued at $501,000 after acquiring an additional 1,088 shares during the last quarter. Finally, Infusive Asset Management Inc. lifted its holdings in Colgate-Palmolive by 744.9% in the fourth quarter. Infusive Asset Management Inc. now owns 77,615 shares of the company’s stock valued at $7,056,000 after acquiring an additional 68,429 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating on the stock in a research note on Monday, March 31st. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a research report on Wednesday, April 2nd. Barclays decreased their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating on the stock in a research note on Friday, April 11th. Finally, UBS Group increased their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average target price of $102.17.

Colgate-Palmolive Stock Up 2.1 %

Shares of CL opened at $95.49 on Friday. The business’s 50 day simple moving average is $91.31 and its 200-day simple moving average is $92.36. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The stock has a market capitalization of $77.45 billion, a price-to-earnings ratio of 27.13, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company posted $0.87 earnings per share. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 59.09%.

Colgate-Palmolive declared that its board has approved a share repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.